ArticlePloS one2025
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib.
Yinli Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticlePloS one2025
Yinli Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.